437 related articles for article (PubMed ID: 35782467)
1. Challenges in Maximizing Impacts of Preventive Strategies against Respiratory Syncytial Virus (RSV) Disease in Young Children.
Zheng Z
Yale J Biol Med; 2022 Jun; 95(2):293-300. PubMed ID: 35782467
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?
Munoz FM
Curr Opin Infect Dis; 2015 Jun; 28(3):221-4. PubMed ID: 25918956
[TBL] [Abstract][Full Text] [Related]
3. Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants.
Browne SK; Beeler JA; Roberts JN
Vaccine; 2020 Jan; 38(2):101-106. PubMed ID: 31706809
[TBL] [Abstract][Full Text] [Related]
4. Passive and active immunization against respiratory syncytial virus for the young and old.
Villafana T; Falloon J; Griffin MP; Zhu Q; Esser MT
Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525961
[TBL] [Abstract][Full Text] [Related]
5. Value profile for respiratory syncytial virus vaccines and monoclonal antibodies.
Fleming JA; Baral R; Higgins D; Khan S; Kochar S; Li Y; Ortiz JR; Cherian T; Feikin D; Jit M; Karron RA; Limaye RJ; Marshall C; Munywoki PK; Nair H; Newhouse LC; Nyawanda BO; Pecenka C; Regan K; Srikantiah P; Wittenauer R; Zar HJ; Sparrow E
Vaccine; 2023 Nov; 41 Suppl 2():S7-S40. PubMed ID: 37422378
[TBL] [Abstract][Full Text] [Related]
6. Current strategies and perspectives for active and passive immunization against Respiratory Syncytial Virus in childhood.
Scotta MC; Stein RT
J Pediatr (Rio J); 2023; 99 Suppl 1(Suppl 1):S4-S11. PubMed ID: 36402228
[TBL] [Abstract][Full Text] [Related]
7. RSV Prevention in All Infants: Which Is the Most Preferable Strategy?
Esposito S; Abu Raya B; Baraldi E; Flanagan K; Martinon Torres F; Tsolia M; Zielen S
Front Immunol; 2022; 13():880368. PubMed ID: 35572550
[TBL] [Abstract][Full Text] [Related]
8. Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children.
Karron RA; Atwell JE; McFarland EJ; Cunningham CK; Muresan P; Perlowski C; Libous J; Spector SA; Yogev R; Aziz M; Woods S; Wanionek K; Collins PL; Buchholz UJ
Am J Respir Crit Care Med; 2021 Mar; 203(5):594-603. PubMed ID: 32871092
[No Abstract] [Full Text] [Related]
9. Parental knowledge about respiratory syncytial virus (RSV) and attitudes to infant immunization with monoclonal antibodies.
Lee Mortensen G; Harrod-Lui K
Expert Rev Vaccines; 2022 Oct; 21(10):1523-1531. PubMed ID: 35929971
[TBL] [Abstract][Full Text] [Related]
10. Priorities for developing respiratory syncytial virus vaccines in different target populations.
Drysdale SB; Barr RS; Rollier CS; Green CA; Pollard AJ; Sande CJ
Sci Transl Med; 2020 Mar; 12(535):. PubMed ID: 32188721
[TBL] [Abstract][Full Text] [Related]
11. A Parainfluenza Virus Vector Expressing the Respiratory Syncytial Virus (RSV) Prefusion F Protein Is More Effective than RSV for Boosting a Primary Immunization with RSV.
Liang B; Matsuoka Y; Le Nouën C; Liu X; Herbert R; Swerczek J; Santos C; Paneru M; Collins PL; Buchholz UJ; Munir S
J Virol; 2020 Dec; 95(2):. PubMed ID: 33115876
[TBL] [Abstract][Full Text] [Related]
12. Maternal RSV vaccine development. Where to from here?
Gunatilaka A; Giles ML
Hum Vaccin Immunother; 2021 Nov; 17(11):4542-4548. PubMed ID: 34499565
[TBL] [Abstract][Full Text] [Related]
13. The preventive effect of vaccine prophylaxis on severe respiratory syncytial virus infection: A meta-analysis.
Zhu T; Zhang C; Yu L; Chen J; Qiu H; Lyu W; Huang S
Virol Sin; 2015 Oct; 30(5):371-8. PubMed ID: 26511990
[TBL] [Abstract][Full Text] [Related]
14. Preventative therapies for respiratory Syncytial virus (RSV) in children: Where are we now?
Bourassa MH; Lands LC
Paediatr Respir Rev; 2024 Mar; 49():24-27. PubMed ID: 37704463
[TBL] [Abstract][Full Text] [Related]
15. Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants.
Rainisch G; Adhikari B; Meltzer MI; Langley G
Vaccine; 2020 Jan; 38(2):251-257. PubMed ID: 31740097
[TBL] [Abstract][Full Text] [Related]
16. A Novel Live Attenuated Respiratory Syncytial Virus Vaccine Candidate with Mutations in the L Protein SAM Binding Site and the G Protein Cleavage Site Is Protective in Cotton Rats and a Rhesus Macaque.
Jenkins T; Wang R; Harder O; Xue M; Chen P; Corry J; Walker C; Teng M; Mejias A; Ramilo O; Niewiesk S; Li J; Peeples ME
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177201
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input Data.
Treskova M; Pozo-Martin F; Scholz S; Schönfeld V; Wichmann O; Harder T
Pharmacoeconomics; 2021 Mar; 39(3):287-315. PubMed ID: 33462760
[TBL] [Abstract][Full Text] [Related]
18. Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries.
Atwell JE; Lutz CS; Sparrow EG; Feikin DR
Vaccine; 2022 Jul; 40(32):4361-4370. PubMed ID: 35725783
[TBL] [Abstract][Full Text] [Related]
19. Epicutaneous immunization using synthetic virus-like particles efficiently boosts protective immunity to respiratory syncytial virus.
Hervé PL; Dhelft V; Zuniga A; Ghasparian A; Rassek O; Yim KC; Donne N; Lambert PH; Benhamou PH; Sampson HA; Mondoulet L
Vaccine; 2021 Jul; 39(32):4555-4563. PubMed ID: 34154864
[TBL] [Abstract][Full Text] [Related]
20. The immunogenicity and safety of respiratory syncytial virus vaccines in development: A systematic review.
Shan J; Britton PN; King CL; Booy R
Influenza Other Respir Viruses; 2021 Jul; 15(4):539-551. PubMed ID: 33764693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
